
ThreoTech LLC settles patent infringement lawsuit on Magtein magnesium L-threonate
ThreoTech LLC has announced that it has reached a confidential settlement with Green Jeeva to end a patent infringement lawsuit regarding Magtein magnesium L-threonate.
ThreoTech LLC has announced that it has reached a confidential settlement with Green Jeeva to end a patent infringement lawsuit regarding Magtein magnesium L-threonate. The lawsuit was originally filed on August 15, 2024 in the Central District of California.
“Magtein is a unique dietary supplement ingredient protected by a variety of composition and use patents,” said Edward Lee, CEO of ThreoTech, LLC, in a press release. “Our patent portfolio and other intellectual property supporting Magtein magnesium L-threonate is strong. We stand ready to protect our intellectual property.”
ThreoTech LLC is the exclusive licensee of a portfolio of patents owned by Neurocentria Inc. Magtein has been shown in research to support
Newsletter
From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.





